Your browser doesn't support javascript.
loading
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype.
Adams, Paul; Altes, Albert; Brissot, Pierre; Butzeck, Barbara; Cabantchik, Ioav; Cançado, Rodolfo; Distante, Sonia; Evans, Patricia; Evans, Robert; Ganz, Tomas; Girelli, Domenico; Hultcrantz, Rolf; McLaren, Gordon; Marris, Ben; Milman, Nils; Nemeth, Elizabeta; Nielsen, Peter; Pineau, Brigitte; Piperno, Alberto; Porto, Graça; Prince, Dianne; Ryan, John; Sanchez, Mayka; Santos, Paulo; Swinkels, Dorine; Teixeira, Emerência; Toska, Ketil; Vanclooster, Annick; White, Desley.
Afiliación
  • Adams P; University Hospital, Western University, London, ON, Canada.
  • Altes A; Asociación Española de Hemocromatosis, Santa Coloma, Spain.
  • Brissot P; Inserm Unit 1241, University Hospital Pontchaillou, Rennes, France. pierre.brissot@univ-rennes1.fr.
  • Butzeck B; HI - Haemochromatosis International, London, UK. pierre.brissot@univ-rennes1.fr.
  • Cabantchik I; HI - Haemochromatosis International, London, UK.
  • Cançado R; European Federation of Associations of Patients with Haemochromatosis, Seine, France.
  • Distante S; Haemochromatose-Vereinigung Deutschland, Hürth, Germany.
  • Evans P; International Bioiron Society, Schaumburg, USA.
  • Evans R; Hebrew University of Jerusalem, Jerusalem, Israel.
  • Ganz T; Division of Hematology, Santa Casa Medical School of Sao Paulo, Sao Paulo, SP, Brazil.
  • Girelli D; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
  • Hultcrantz R; HI - Haemochromatosis International, London, UK.
  • McLaren G; European Federation of Associations of Patients with Haemochromatosis, Seine, France.
  • Marris B; HI - Haemochromatosis International, London, UK.
  • Milman N; Department of Electronic and Computer Engineering, School of Engineering and Design, Brunel University, Uxbridge, UK.
  • Nemeth E; The Haemochromatosis Society, Hertfordshire, UK.
  • Nielsen P; David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Pineau B; Department of Medicine, University of Verona Veneto Region Referral Center for Iron Metabolism Disorders, Verona, Italy.
  • Piperno A; Department of Medicine, Unit of Gastroenterology and Rheumatology, Karolinska Institutet, Stockholm, Sweden.
  • Porto G; Division of Hematology/Oncology, University of California, Irvine, CA, USA.
  • Prince D; HI - Haemochromatosis International, London, UK.
  • Ryan J; Haemochromatosis Australia, Meridan Plains, Australia.
  • Sanchez M; Danish Haemochromatosis Association, Copenhagen, Denmark.
  • Santos P; Center for Iron Disorders, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Swinkels D; Institut für Biochemie und Molekulare Zellbiologie, University Medical Center Hamburg, Hamburg, Germany.
  • Teixeira E; Fédération Française des Associations de Malades de l'hémochromatose, Paris, France.
  • Toska K; Department of Medicine and Surgery, Centre for Rare Diseases, University of Milano-Bicocca, Monza, Italy.
  • Vanclooster A; Association for the Study of Hemochromatosis and Iron Overload Diseases, Monza, Italy.
  • White D; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.
Hepatol Int ; 12(2): 83-86, 2018 Mar.
Article en En | MEDLINE | ID: mdl-29589198
Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hemocromatosis Tipo de estudio: Guideline Idioma: En Revista: Hepatol Int Año: 2018 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hemocromatosis Tipo de estudio: Guideline Idioma: En Revista: Hepatol Int Año: 2018 Tipo del documento: Article País de afiliación: Canadá